Ambu’s VivaSight-DL

Patient Safety

Study: VivaSight-DL Double Lumen Tube Offers Advantages in Esophageal Surgery

A comparative study of Ambu’s VivaSight-DL with Mallinckrodt’s Broncho-Cath found that the Ambu device’s ability to continuously visually monitor the double lumen tube offered several advantages.

A comparative study of Ambu’s VivaSight-DL with Mallinckrodt’s Broncho-Cath found that the Ambu device’s ability to continuously visually monitor the double lumen tube offered several advantages.

It enabled immediate repositioning as needed and visual feedback of the endobronchial cuff. It also reduced the quantity of equipment required while being cost neutral, the authors write.

The VivaSight device was connected to the Ambu aView screen through the provided purpose-built cables, which guarantee continuous visual feedback throughout induction, intubation and surgery. The lens is cleared by a suction/flush port.

Esophagectomies are surgeries to remove some or most of the esophagus, which is the swallowing tube between a person’s mouth and stomach.

The authors of the study, conducted at Wrexham Maelor Hospital in the United Kingdom, report that the fixed optics also improved left and right identification, which is especially helpful once a patient is put in a prone position.

The hospital does about 50 such surgeries each year and designed the study to pilot the use of the left sided VivaSight-DL DLT during esophageal surgery as an alternative to the single-use DLT (Mallinckrodt’s Broncho-Cath) and flexible bronchoscope (the Ambu aView 4 slim). The VivaSight is similar in length and diameter to the Mallinckrodt.

The authors note that if secretion clearance or direct visualization beyond the tracheal lumen or via the bronchial lumen is necessary, a flexible bronchoscope should also be available.

Ambu’s VivaSight showed no heating during the trial and there were no documented airway complications. Staff reported being satisfied with the performance of the equipment, the authors write.

The cost of a double lumen tube combined with a single-use flexible bronchoscope is comparable to the cost of a VivaSight-DL.

Esophageal surgery carries a substantial associated morbidity and mortality with a 25 percent, five-year survival rate, according to the authors.

 

More Thoracic Anesthesiology Articles
Study: VivaSight-DL Double Lumen Tube Offers Advantages in Esophageal Surgery
Patient Safety
Researchers looked at 12 patients undergoing elective esophagectomies and were intubated using an Ambu VivaSight-DL – which has a built-in camera at the distal tracheal lumen – connected to a monitor. The VivaSight provided continuous quality images and eliminated the need for bronchoscopy.
Airway Management in COVID-19 Pandemic
Performing Procedures
Society guidelines offer safety recommendations for anesthesiologists during novel coronavirus pandemic.
More From Single-Use Endoscopy

Emerging Technologies

Physicians, researchers, and other industry professionals will gather in San Diego for Digestive Disease Week 2022 after the COVID-19 pandemic forced the event to go virtual each of the past two years.

5 Things Urologists Were Talking About at AUA 2022

Endoscopy Tech

Patient engagement and advancing diversity in urologic oncology were among the topics probed over three days in New Orleans as the American Urology Association held its annual meeting.

A Matter of Time: Shifting the Healthcare Paradigm With Single-Use

Emerging Technologies

At DeviceTalks Boston, med-tech executives talk of a day when single-use endoscopy is the standard of care and reusable endoscopes are “hanging in a museum.”